Systemic immunotoxin therapy of cancer: advances and prospects

This publication has 54 references indexed in Scilit:

• Strategies in antibody therapy of cancer
  Clinical and Experimental Immunology, 2008
• Blocked and non-blocked ricin immunotoxins against the CD4 antigen exhibit higher cytotoxic potency than a ricin A chain immunotoxin potentiated with ricin B chain or with a ricin B chain immunotoxin
  Cancer Immunology, Immunotherapy, 1991
• The galactose-binding sites of the cytotoxic lectin ricin can be chemically blocked in high yield with reactive ligands prepared by chemical modification of glycopeptides containing triantennary N-linked oligosaccharides
  Biochemistry, 1991
• Covalent binding of human alpha 2-macroglobulin to deglycosylated ricin A chain and its immunotoxins.
  1991
• Biochemical, cytotoxic and pharmacokinetic properties of an immunotoxin composed of a mouse monoclonal antibody Fib75 and the ribosome‐inactivating protein α‐sarcin from Aspergillus giganteus
  European Journal of Biochemistry, 1991
• Comparative biochemical, cytotoxic and pharmacokinetic properties of immunotoxins made with native ricin a chain, ricin A1 chain and recombinant ricin a chain
  International Journal of Cancer, 1991
• Preclinical assessments of 90Y-labeled C110 anti-carcinoembryonic antigen immunotoxin: a therapeutic immunoconjugate for human colon cancer.
  1991
• PHARMACOKINETICS IN THE RAT OF A PANEL OF IMMUNOTOXINS MADE WITH ABRIN-A CHAIN, RICIN-A CHAIN, GELONIN, AND MOMORDIN
  1990
• A recombinant single-chain immunotoxin composed of anti-Tac variable regions and a truncated diphtheria toxin.
  Proceedings of the National Academy of Sciences, 1990
• Cytotoxicity of a recombinant ricin‐A‐chain fusion protein containing a proteolytically‐cleavable spacer sequence
  FEBS Letters, 1990